Publications
2 shownGefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Gefitinib is superior to carboplatin-paclitaxel as an initial treatment for pulmonary adenocarcinoma among nonsmokers or former light smokers in East Asia. The presence in the t...
Frequent Co-Authors
Researcher Info
- h-index
- 2
- Publications
- 2
- Citations
- 9,352
- Institution
- AstraZeneca (United Kingdom)
External Links
Impact Metrics
h-index
2
h-index: Number of publications with at least h citations each.